|
|
Nutrition Initiative for Small Chain Restaurants (NISCR)
|
1R43CA135998-01A1
|
$99,979
|
|
HILL, ESTHER
|
ACCENTS ON HEALTH, INC.
|
|
|
Patient-specific therapy of glioblastoma using lightly-labeled [14C]-temozolomide
|
1R43CA134184-01
|
$102,900
|
|
Arjomand, Ali
|
ACCIUM BIOSCIENCES, INC.
|
|
|
Precisely Shaped Acoustic Ablation of Tumors Under 3D Ultrasound Image Guidance
|
1R44CA134169-01A1
|
$150,000
|
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
|
Add-on module for ONCAD for diagnosing infiltrating lobular carcinoma
|
1R43CA132259-01A1
|
$100,058
|
|
PENN, ALAN
|
ALAN PENN AND ASSOCIATES, INC.
|
|
|
Education for Healthcare Providers of Alaska Natives
|
5R25CA104120-05
|
$307,210
|
|
Lanier, Anne
|
ALASKA NATIVE TRIBAL HEALTH CONSORTIUM
|
|
|
Experimental Models for Testing Novel Targets for Pancreatic Cancer Cell Invasion
|
1R21CA124931-01A1
|
$167,475
|
|
MOUSA, SHAKER
|
ALBANY COLLEGE OF PHARMACY
|
|
|
Fibronectin Polymerization: Effects on Cell Signaling
|
5R01CA069612-12
|
$271,548
|
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
|
Computer-aided tool for diagnostic breast ultrasound
|
5R44CA112858-03
|
$443,533
|
|
Galperin, Michael
|
ALMEN LABORATORIES, INC.
|
|
|
A Novel Non-Invasive CRC Test Based on Mass Spec Of In Vitro Expressed Proteins
|
5R44CA119565-03
|
$455,651
|
|
Han, James
|
AMBERGEN, INC
|
|
|
ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE
|
2R44CA114126-02
|
$419,983
|
|
Lim, Mark
|
AMBERGEN, INC
|
|
|
Novel RNA Markers for Detecting Colon Cancer Metastasis
|
1R43CA130238-01A2
|
$277,748
|
|
Beaudenon, Sylvie
|
AMBION DIAGNOSTICS, INC.
|
|
|
Young Minority Scientists in the Field of Cancer
|
5R13CA040577-23
|
$214,489
|
|
CLARKSON, BAYARD
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
|
MSI Faculty in the Field of Cancer
|
5R13CA076526-12
|
$78,120
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
|
Improving colonoscopic miss rate by real time microvascular blood analysis
|
4R42CA130508-02
|
$394,745
|
|
Roy, Hemant
|
AMERICAN BIOOPTICS, LLC
|
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
|
2U01CA098710-05
|
$1,063,219
|
|
THUN, MICHAEL
|
AMERICAN CANCER SOCIETY, INC.
|
|
|
QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCS
|
5R01CA065435-10
|
$740,839
|
|
WILSON, JESSE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Novel Approach to Enhance Cord Blood-Mediated Bone Marrow Homing and Engraftment
|
1R43CA139602-01
|
$193,658
|
$193,658
|
MILLER, LEONARD
|
AMERICAN STEM CELL, INC.
|
|
|
Adenoviral GFP targeting of metastatic human tumors using multiple delivery route
|
1R43CA132242-01
|
$149,575
|
|
Kishimoto, Hiroyuki
|
ANTICANCER, INC.
|
|
|
Hybrid synthetic targeted lenti-VLP nanoparticle for gene delivery
|
1R43CA137966-01
|
$299,600
|
|
WOODLE, MARTIN
|
APARNA BIOSCIENCES CORPORATION
|
|
|
402 - RFP: N43-CM-87007-68 TOPIC 251: DEVELOPMENT OF ANTICANCER AGENTS REQUEST
|
N43CM800026-000
|
$149,558
|
|
CASTOR, TREVOR
|
APHIOS CORP:1105999
|
|
|
SBIR Phase I- Topic 247- Portable e-Technology Diet and Physical Activity Tools f
|
N43CO800037-000
|
$149,955
|
|
LI, HUIPING
|
APPLIED MEDIA ANALYSIS INC:1145653
|
|
|
Human Apyrase to Disrupt Cancer Therapy
|
1R43CA130192-01A2
|
$196,745
|
|
CHEN, RIDONG
|
APT THERAPEUTICS, INC.
|
|
|
An Exploration of Perceived Racial/Ethnic Discrimination in Cancer Care Delivery
|
5R03CA124752-02
|
$77,999
|
|
Campesino, Maureen
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Microfluidics-Based Platform for Screening Combinatorial Drug Treatments
|
1R21CA131891-01A1
|
$210,715
|
|
Rege, Kaushal
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
PHASE I AND II CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
|
N01CN035158-009
|
$1,500,000
|
|
CHOW, SHERRY
|
ARIZONA UNIV:1109859
|
|
|
Image-Guided System for Cancer Intervention
|
2R42CA115112-02A2
|
$591,060
|
|
Vosburgh, Kirby
|
ASCENSION TECHNOLOGY CORPORATION
|
|
|
CellWell?: A microdevice for single cell analysis
|
7R21CA133551-02
|
$138,750
|
|
NETTIKADAN, SAJU
|
ASPERA CORPORATION
|
|
|
Antibody therapeutics - feasibility study on hormone-refrectory prostate cancer m
|
1R43CA137929-01
|
$185,061
|
|
CHANG, JIA
|
ATTOGEN, INC
|
|
|
Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins
|
5R01CA125063-02
|
$373,539
|
|
PETRENKO, VALERY
|
AUBURN UNIVERSITY AT AUBURN
|
|
|
Targeted Gene Therapy for Lymphoma
|
5R01CA113454-03
|
$256,177
|
|
SMITH, BRUCE
|
AUBURN UNIVERSITY AT AUBURN
|
|
|
SURVEILLANCE SUPPORT SERVICES FOR THE NATIONAL CANCER INSTITUTE
|
N02PC513001-003
|
$859
|
|
MANNINEN, DIANE
|
BATTELLE MEMORIAL INSTITUTE:1107037
|
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-19
|
$481,201
|
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
|
Targeting Relaxin Signaling in Prostate Cancer
|
5R21CA118362-02
|
$150,000
|
|
Agoulnik, Alexander
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
PROP SENSITIVITY AND OBESITY AMONG ETHNIC CHILDREN
|
5R01CA116766-04
|
$391,200
|
|
Baranowski, Tom
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Molecular Mechanisms by which Rexinoids Prevent Breast Cancer
|
5R01CA078480-11
|
$341,085
|
|
BROWN, POWEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
SV40 Pathogenesis of Human Infections
|
5R01CA104818-05
|
$467,229
|
$233,615
|
BUTEL, JANET
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Breast cancer response markers to a dual HER1/2 blocker
|
5R01CA112305-04
|
$252,236
|
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
NR4A Nuclear Receptor Function in Leukemia
|
5R01CA111411-03
|
$258,529
|
|
CONNEELY, ORLA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Family Eats: Cancer Prevention for Families
|
1R01CA124505-01A1
|
$360,449
|
|
CULLEN, KAREN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Guideline-based surveillance and treatment of hepatocellular carcinoma
|
5R01CA160738-03
|
$244,203
|
$244,203
|
Davila, Jessica
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Contributions of Epstein-Barr Virus EBNA2 and EBNA-LP to B cell immortalization
|
5F31CA126523-02
|
$35,140
|
|
Echendu, Chisaroka
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Obesity, H pylori and Risk of Barrett's Esophagus
|
5R01CA116845-02
|
$562,889
|
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Proteosome Inhibition Therapy for Hematologic Malignancy
|
5K23CA113775-03
|
$134,015
|
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy
|
5R01CA104035-04
|
$280,899
|
|
JING, NAIJIE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Role of PML nuclear body proteins for establishment of EBV latent infection
|
5R01CA124309-03
|
$258,530
|
|
Ling, Paul
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Novel Gene Networks in Breast Development and Cancer
|
5P01CA030195-26
|
$2,398,875
|
|
Oesterreich, Steffi
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Translational Research in Breast Cancer
|
2P50CA058183-14
|
$2,300,000
|
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$1,173
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S1
|
$75,000
|
$750
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S2
|
$43,265
|
$433
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Total relevant funding to Organ Transplantation Research for this search: $81,518,757
|
